Cargando…
Insights into new-onset autoimmune diseases after COVID-19 vaccination
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and almost 7 million deaths globally. The emergence of numerous SARS-CoV-2 has heightened public concern regarding the future course of the ep...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108562/ https://www.ncbi.nlm.nih.gov/pubmed/37075917 http://dx.doi.org/10.1016/j.autrev.2023.103340 |
_version_ | 1785026874341064704 |
---|---|
author | Guo, Ming Liu, Xiaoxiao Chen, Xiangmei Li, Qinggang |
author_facet | Guo, Ming Liu, Xiaoxiao Chen, Xiangmei Li, Qinggang |
author_sort | Guo, Ming |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and almost 7 million deaths globally. The emergence of numerous SARS-CoV-2 has heightened public concern regarding the future course of the epidemic. Currently, the SARS-CoV-2 Omicron variant has rapidly become globally dominant in the COVID-19 pandemic due to its high infectivity and immune evasion. Consequently, vaccination implementation is critically significant. However, growing evidence suggests that COVID-19 vaccination may cause new-onset autoimmune diseases, including autoimmune glomerulonephritis, autoimmune rheumatic diseases, and autoimmune hepatitis. Nevertheless, the causal relationship between COVID-19 vaccines and these autoimmune diseases remains to be demonstrated. In this review, we provide evidence that vaccination induces autoimmunity and summarize possible mechanisms of action, such as molecular mimicry, activation by bystanders, and adjuvants. Our objective is not to refute the importance of vaccines, but to raise awareness about the potential risks of COVID-19 vaccination. In fact, we believe that the benefits of vaccination far outweigh the possible risks and encourage people to get vaccinated. |
format | Online Article Text |
id | pubmed-10108562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101085622023-04-18 Insights into new-onset autoimmune diseases after COVID-19 vaccination Guo, Ming Liu, Xiaoxiao Chen, Xiangmei Li, Qinggang Autoimmun Rev Article Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and almost 7 million deaths globally. The emergence of numerous SARS-CoV-2 has heightened public concern regarding the future course of the epidemic. Currently, the SARS-CoV-2 Omicron variant has rapidly become globally dominant in the COVID-19 pandemic due to its high infectivity and immune evasion. Consequently, vaccination implementation is critically significant. However, growing evidence suggests that COVID-19 vaccination may cause new-onset autoimmune diseases, including autoimmune glomerulonephritis, autoimmune rheumatic diseases, and autoimmune hepatitis. Nevertheless, the causal relationship between COVID-19 vaccines and these autoimmune diseases remains to be demonstrated. In this review, we provide evidence that vaccination induces autoimmunity and summarize possible mechanisms of action, such as molecular mimicry, activation by bystanders, and adjuvants. Our objective is not to refute the importance of vaccines, but to raise awareness about the potential risks of COVID-19 vaccination. In fact, we believe that the benefits of vaccination far outweigh the possible risks and encourage people to get vaccinated. Elsevier B.V. 2023-07 2023-04-17 /pmc/articles/PMC10108562/ /pubmed/37075917 http://dx.doi.org/10.1016/j.autrev.2023.103340 Text en © 2023 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Guo, Ming Liu, Xiaoxiao Chen, Xiangmei Li, Qinggang Insights into new-onset autoimmune diseases after COVID-19 vaccination |
title | Insights into new-onset autoimmune diseases after COVID-19 vaccination |
title_full | Insights into new-onset autoimmune diseases after COVID-19 vaccination |
title_fullStr | Insights into new-onset autoimmune diseases after COVID-19 vaccination |
title_full_unstemmed | Insights into new-onset autoimmune diseases after COVID-19 vaccination |
title_short | Insights into new-onset autoimmune diseases after COVID-19 vaccination |
title_sort | insights into new-onset autoimmune diseases after covid-19 vaccination |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108562/ https://www.ncbi.nlm.nih.gov/pubmed/37075917 http://dx.doi.org/10.1016/j.autrev.2023.103340 |
work_keys_str_mv | AT guoming insightsintonewonsetautoimmunediseasesaftercovid19vaccination AT liuxiaoxiao insightsintonewonsetautoimmunediseasesaftercovid19vaccination AT chenxiangmei insightsintonewonsetautoimmunediseasesaftercovid19vaccination AT liqinggang insightsintonewonsetautoimmunediseasesaftercovid19vaccination |